FDA Embraces Emerging Technology for Bioequivalence Evaluation

In their media release, the FDA indicated that the use of data obtained using Morphology Directed Raman Spectroscopy (MDRS) allowed them to validate the bioequivalence of the two products without the need for costly clinical endpoint bioequivalence s…

from Water Technology-Updates http://ift.tt/2bpo91S
via IFTTT